| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -28.71M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KROS returned -29.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -45.8% |
| 1 year | -29.1% |
| 5 years | -67.2% |
| All-time high | $75.61 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KROS would be worth today ›No. Keros Therapeutics, Inc. has not paid a dividend in the past 12 months.
Keros Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol KROS.
Keros Therapeutics, Inc. is part of the Healthcare sector.
Keros Therapeutics, Inc. has a market cap of 218.69M USD, based on the latest quote.
